| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |